Loading chat...

AL SB120

Bill

Status

Engrossed

3/10/2022

Primary Sponsor

Del Marsh

Click for details

Origin

Senate

Regular Session 2022

AI Summary

SB120 Summary

  • Expands scope of optometry practice to include prescribing and administering narcotic analgesics (except Schedule I, II, and Hydrocodone-containing Schedule III drugs), with other Schedule III agents limited to 96-hour prescriptions.

  • Authorizes optometrists to perform specific procedures including injections for macular/retinal disease, chalazion removal, skin lesion biopsy, laser capsulotomy, laser trabeculoplasty, laser peripheral iridotomy, and corneal crosslinking, while prohibiting injections into the eyeball, cataract surgery, muscle surgery, retinal surgery, and other invasive ophthalmic surgeries.

  • Grants Alabama Board of Optometry authority to issue advisory opinions and declaratory rulings related to optometry practice and administrative rules.

  • Establishes Alabama Board of Optometry as a certifying board under the Uniform Controlled Substances Act, with specified limitations from Chapter 22 of Title 34.

  • Prohibits optometrists from using the word "surgeon" in advertisements or signage and authorizes administration of epinephrine or benadryl to counteract anaphylaxis.

Legislative Description

Optometrists, practice of optometry further provided, Board of Optometry to regulate, to issue advisory opinions and declaratory rulings, Secs. 20-2-2, 34-22-1, 34-22-42 am'd.

Optometry, Alabama Board of

Last Action

Read for the first time and referred to the House of Representatives committee on Health

3/10/2022

Committee Referrals

Health3/10/2022
Healthcare1/18/2022

Full Bill Text

No bill text available